 | • レポートコード：MRC2312MG14880 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、69ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のジェネリック医薬品中間体CDMOサービス市場規模と予測を収録しています。・世界のジェネリック医薬品中間体CDMOサービス市場：売上、2018年-2023年、2024年-2029年 ・世界のジェネリック医薬品中間体CDMOサービス市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のジェネリック医薬品中間体CDMOサービス市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「中間体プロセス最適化」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ジェネリック医薬品中間体CDMOサービスのグローバル主要企業は、Euroapi、 Cambrex、 Recipharm、 Thermo Fisher Scientific、 Wuxi New Drug Development、 Pharmaron Beijing、 Asymchem Laboratories、 Porton Pharma Solutions、 ChengDa Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ジェネリック医薬品中間体CDMOサービスのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のジェネリック医薬品中間体CDMOサービス市場：タイプ別、2018年-2023年、2024年-2029年 世界のジェネリック医薬品中間体CDMOサービス市場：タイプ別市場シェア、2022年 ・中間体プロセス最適化、中間体製造 世界のジェネリック医薬品中間体CDMOサービス市場：用途別、2018年-2023年、2024年-2029年 世界のジェネリック医薬品中間体CDMOサービス市場：用途別市場シェア、2022年 ・製薬企業、研究所、その他 世界のジェネリック医薬品中間体CDMOサービス市場：地域・国別、2018年-2023年、2024年-2029年 世界のジェネリック医薬品中間体CDMOサービス市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるジェネリック医薬品中間体CDMOサービスのグローバル売上、2018年-2023年 ・主要企業におけるジェネリック医薬品中間体CDMOサービスのグローバル売上シェア、2022年 ・主要企業におけるジェネリック医薬品中間体CDMOサービスのグローバル販売量、2018年-2023年 ・主要企業におけるジェネリック医薬品中間体CDMOサービスのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Euroapi、 Cambrex、 Recipharm、 Thermo Fisher Scientific、 Wuxi New Drug Development、 Pharmaron Beijing、 Asymchem Laboratories、 Porton Pharma Solutions、 ChengDa Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 ジェネリック医薬品中間体CDMOサービス市場の定義 市場セグメント 世界のジェネリック医薬品中間体CDMOサービス市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のジェネリック医薬品中間体CDMOサービス市場規模 世界のジェネリック医薬品中間体CDMOサービス市場規模：2022年 VS 2029年 世界のジェネリック医薬品中間体CDMOサービス市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのジェネリック医薬品中間体CDMOサービスの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のジェネリック医薬品中間体CDMOサービス製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：中間体プロセス最適化、中間体製造 ジェネリック医薬品中間体CDMOサービスのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：製薬企業、研究所、その他 ジェネリック医薬品中間体CDMOサービスの用途別グローバル売上・予測 ・地域別市場分析 地域別ジェネリック医薬品中間体CDMOサービス市場規模 2022年と2029年 地域別ジェネリック医薬品中間体CDMOサービス売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Euroapi、 Cambrex、 Recipharm、 Thermo Fisher Scientific、 Wuxi New Drug Development、 Pharmaron Beijing、 Asymchem Laboratories、 Porton Pharma Solutions、 ChengDa Pharmaceuticals ... |
This research report provides a comprehensive analysis of the Generic Drug Intermediates CDMO Services market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Generic Drug Intermediates CDMO Services market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Generic Drug Intermediates CDMO Services, challenges faced by the industry, and potential opportunities for market players.
The global Generic Drug Intermediates CDMO Services market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Generic Drug Intermediates CDMO Services market presents opportunities for various stakeholders, including Pharmaceutical Enterprise, Laboratory. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Generic Drug Intermediates CDMO Services market. Additionally, the growing consumer demand present avenues for market expansion.
The global Generic Drug Intermediates CDMO Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The market prospects for Generic Drug Intermediates CDMO (Contract Development Manufacturing Organization) Services are expected to be strong. The demand for generic drugs continues to rise due to their cost-effectiveness and increasing focus on accessible healthcare. Generic drug manufacturers often seek specialized services from CDMOs for efficient and streamlined processes in the development and manufacturing of drug intermediates. CDMOs offer expertise, regulatory compliance, and cost-effective manufacturing solutions. As the pharmaceutical industry strives to meet the growing demand for generic drugs, the market for Generic Drug Intermediates CDMO Services is projected to expand, providing pharmaceutical companies with essential support to deliver high-quality and affordable medications.
Key Features:
The research report on the Generic Drug Intermediates CDMO Services market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Generic Drug Intermediates CDMO Services market.
Market Overview: The report provides a comprehensive overview of the Generic Drug Intermediates CDMO Services market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Process Optimization of Generic Intermediates, Production of Generic Intermediates), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Generic Drug Intermediates CDMO Services market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Generic Drug Intermediates CDMO Services market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Generic Drug Intermediates CDMO Services market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Generic Drug Intermediates CDMO Services market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Generic Drug Intermediates CDMO Services market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Generic Drug Intermediates CDMO Services market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Generic Drug Intermediates CDMO Services, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Generic Drug Intermediates CDMO Services market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Generic Drug Intermediates CDMO Services market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Process Optimization of Generic Intermediates
Production of Generic Intermediates
Market segment by Application
Pharmaceutical Enterprise
Laboratory
Other
Global Generic Drug Intermediates CDMO Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Euroapi
Cambrex
Recipharm
Thermo Fisher Scientific
Wuxi New Drug Development
Pharmaron Beijing
Asymchem Laboratories
Porton Pharma Solutions
ChengDa Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Generic Drug Intermediates CDMO Services, market overview.
Chapter 2: Global Generic Drug Intermediates CDMO Services market size in revenue.
Chapter 3: Detailed analysis of Generic Drug Intermediates CDMO Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Generic Drug Intermediates CDMO Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Generic Drug Intermediates CDMO Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Drug Intermediates CDMO Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Generic Drug Intermediates CDMO Services Overall Market Size
2.1 Global Generic Drug Intermediates CDMO Services Market Size: 2022 VS 2029
2.2 Global Generic Drug Intermediates CDMO Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Generic Drug Intermediates CDMO Services Players in Global Market
3.2 Top Global Generic Drug Intermediates CDMO Services Companies Ranked by Revenue
3.3 Global Generic Drug Intermediates CDMO Services Revenue by Companies
3.4 Top 3 and Top 5 Generic Drug Intermediates CDMO Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Generic Drug Intermediates CDMO Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Generic Drug Intermediates CDMO Services Players in Global Market
3.6.1 List of Global Tier 1 Generic Drug Intermediates CDMO Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Generic Drug Intermediates CDMO Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Generic Drug Intermediates CDMO Services Market Size Markets, 2022 & 2029
4.1.2 Process Optimization of Generic Intermediates
4.1.3 Production of Generic Intermediates
4.2 By Type – Global Generic Drug Intermediates CDMO Services Revenue & Forecasts
4.2.1 By Type – Global Generic Drug Intermediates CDMO Services Revenue, 2018-2023
4.2.2 By Type – Global Generic Drug Intermediates CDMO Services Revenue, 2024-2029
4.2.3 By Type – Global Generic Drug Intermediates CDMO Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Generic Drug Intermediates CDMO Services Market Size, 2022 & 2029
5.1.2 Pharmaceutical Enterprise
5.1.3 Laboratory
5.1.4 Other
5.2 By Application – Global Generic Drug Intermediates CDMO Services Revenue & Forecasts
5.2.1 By Application – Global Generic Drug Intermediates CDMO Services Revenue, 2018-2023
5.2.2 By Application – Global Generic Drug Intermediates CDMO Services Revenue, 2024-2029
5.2.3 By Application – Global Generic Drug Intermediates CDMO Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Generic Drug Intermediates CDMO Services Market Size, 2022 & 2029
6.2 By Region – Global Generic Drug Intermediates CDMO Services Revenue & Forecasts
6.2.1 By Region – Global Generic Drug Intermediates CDMO Services Revenue, 2018-2023
6.2.2 By Region – Global Generic Drug Intermediates CDMO Services Revenue, 2024-2029
6.2.3 By Region – Global Generic Drug Intermediates CDMO Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Generic Drug Intermediates CDMO Services Revenue, 2018-2029
6.3.2 US Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.3.3 Canada Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.3.4 Mexico Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Generic Drug Intermediates CDMO Services Revenue, 2018-2029
6.4.2 Germany Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.4.3 France Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.4.4 U.K. Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.4.5 Italy Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.4.6 Russia Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.4.7 Nordic Countries Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.4.8 Benelux Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Generic Drug Intermediates CDMO Services Revenue, 2018-2029
6.5.2 China Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.5.3 Japan Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.5.4 South Korea Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.5.5 Southeast Asia Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.5.6 India Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Generic Drug Intermediates CDMO Services Revenue, 2018-2029
6.6.2 Brazil Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.6.3 Argentina Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Generic Drug Intermediates CDMO Services Revenue, 2018-2029
6.7.2 Turkey Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.7.3 Israel Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.7.4 Saudi Arabia Generic Drug Intermediates CDMO Services Market Size, 2018-2029
6.7.5 UAE Generic Drug Intermediates CDMO Services Market Size, 2018-2029
7 Generic Drug Intermediates CDMO Services Companies Profiles
7.1 Euroapi
7.1.1 Euroapi Company Summary
7.1.2 Euroapi Business Overview
7.1.3 Euroapi Generic Drug Intermediates CDMO Services Major Product Offerings
7.1.4 Euroapi Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.1.5 Euroapi Key News & Latest Developments
7.2 Cambrex
7.2.1 Cambrex Company Summary
7.2.2 Cambrex Business Overview
7.2.3 Cambrex Generic Drug Intermediates CDMO Services Major Product Offerings
7.2.4 Cambrex Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.2.5 Cambrex Key News & Latest Developments
7.3 Recipharm
7.3.1 Recipharm Company Summary
7.3.2 Recipharm Business Overview
7.3.3 Recipharm Generic Drug Intermediates CDMO Services Major Product Offerings
7.3.4 Recipharm Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.3.5 Recipharm Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Major Product Offerings
7.4.4 Thermo Fisher Scientific Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 Wuxi New Drug Development
7.5.1 Wuxi New Drug Development Company Summary
7.5.2 Wuxi New Drug Development Business Overview
7.5.3 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Major Product Offerings
7.5.4 Wuxi New Drug Development Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.5.5 Wuxi New Drug Development Key News & Latest Developments
7.6 Pharmaron Beijing
7.6.1 Pharmaron Beijing Company Summary
7.6.2 Pharmaron Beijing Business Overview
7.6.3 Pharmaron Beijing Generic Drug Intermediates CDMO Services Major Product Offerings
7.6.4 Pharmaron Beijing Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.6.5 Pharmaron Beijing Key News & Latest Developments
7.7 Asymchem Laboratories
7.7.1 Asymchem Laboratories Company Summary
7.7.2 Asymchem Laboratories Business Overview
7.7.3 Asymchem Laboratories Generic Drug Intermediates CDMO Services Major Product Offerings
7.7.4 Asymchem Laboratories Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.7.5 Asymchem Laboratories Key News & Latest Developments
7.8 Porton Pharma Solutions
7.8.1 Porton Pharma Solutions Company Summary
7.8.2 Porton Pharma Solutions Business Overview
7.8.3 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Major Product Offerings
7.8.4 Porton Pharma Solutions Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.8.5 Porton Pharma Solutions Key News & Latest Developments
7.9 ChengDa Pharmaceuticals
7.9.1 ChengDa Pharmaceuticals Company Summary
7.9.2 ChengDa Pharmaceuticals Business Overview
7.9.3 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Major Product Offerings
7.9.4 ChengDa Pharmaceuticals Generic Drug Intermediates CDMO Services Revenue in Global Market (2018-2023)
7.9.5 ChengDa Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
